No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
CbdMD FY24 EPS $(1.79) Up From $(13.32) YoY; Revenue $19.48M Down From $24.16M YoY
cbdMD | 10-K: FY2024 Annual Report
CbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
CbdMD Postpones Release Of Q4 Financial Results And Conference Call To December 18, 2024, Citing Additional Time Needed To Complete Its Year-end Reporting Process
Earnings Scheduled For December 17, 2024
CbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Unlock the Full List